Diltiazem
Brand names: Cardizem, Cardizem CD, Cardizem LA, Cartia, DILT-CD, DILTIAZEM HYDROCHLORIDE, DILTZAC, Dilacor, Diltiazem HCl CD, Diltiazem Hydrochloride, Diltiazem Hydrochloride Extended Release, Diltiazem HydrochlorideExtended Release, Diltiazem hydrochloride, Matzim LA, TAZTIA, TIADYLT ER, TIAZAC, Tiazac Extended Release, diltiazem hydrochloride
Warnings
No boxed warning. Diltiazem is contraindicated in patients with "sick sinus syndrome except in the presence of a functioning ventricular pacemaker," "second- or third-degree AV block" (without a pacemaker), "hypotension (less than 90 mm Hg systolic)," and acute myocardial infarction with pulmonary congestion documented by X-ray. Key warnings cover cardiac conduction abnormalities, including "second- or third-degree AV block" reported in a small percentage of patients, potential worsening of congestive heart failure in patients with ventricular dysfunction, and symptomatic hypotension.
Uses
Diltiazem hydrochloride extended-release capsules are indicated for: - "Treatment of hypertension," alone or in combination with other antihypertensive medications - "Management of chronic stable angina" and "angina due to coronary artery spasm (vasospastic angina)"
Dosage forms & strengths
All identified pills
Tiazac 240
BLUE;PURPLE CAPSULE · Diltiazem
3 manufacturers
Tiazac 300
WHITE;PURPLE CAPSULE · Diltiazem
2 manufacturers
Tiazac 300
PURPLE;WHITE CAPSULE · Diltiazem
WPI 3362
WHITE ROUND · Diltiazem
6 manufacturers
cardizem CD
BLUE CAPSULE · Diltiazem
cardizem CD
BLUE CAPSULE · Diltiazem
cardizem CD
BLUE CAPSULE · Diltiazem
3 manufacturers
cardizem CD
BLUE CAPSULE · Diltiazem
cardizem CD
BLUE CAPSULE · Diltiazem
3 manufacturers
cardizem CD
BLUE CAPSULE · Diltiazem
cardizem CD
BLUE CAPSULE · Diltiazem
2 manufacturers
cardizem CD
BLUE CAPSULE · Diltiazem
cardizem CD
GRAY CAPSULE · Diltiazem
cardizem CD
GRAY CAPSULE · Diltiazem
par C829
GRAY;GRAY CAPSULE · Diltiazem
16 manufacturers
par C830
BLUE;GREEN CAPSULE · Diltiazem
2 manufacturers
par C831
GREEN;GREEN CAPSULE · Diltiazem
8 manufacturers
par C830
GREEN;BLUE CAPSULE · Diltiazem
8 manufacturers
par C832
GREEN;GRAY CAPSULE · Diltiazem
5 manufacturers
Side effects
In placebo-controlled trials, the most frequently reported adverse reactions were "headache" (5.4%), "bradycardia" (3.3%), "first-degree AV block" (3.3%), "dizziness" (3.0%), and "edema" (2.6%). Other reported effects include flushing, nausea, and asthenia; rare but serious events reported in postmarketing experience include AV block and allergic skin reactions.